Cite
HARVARD Citation
Staessen, J. et al. (2022). Predictive performance and clinical application of COV50, a urinary proteomic biomarker in early COVID-19 infection: a prospective multicentre cohort study. Lancet. 4 (10), pp. e727-e737. [Online].